Novartis AG vs VNET Group Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while VNET Group Inc trades at $7.7 (market cap $2.19B). The key difference: Novartis AG is far larger — about 132.5× VNET Group Inc's market cap, and Novartis AG pays a 3.17% dividend while VNET Group Inc pays none. Which is the better fit depends on your goals.
| NVS | VNET | |
|---|---|---|
Market Cap | $290.25B | $2.19B |
Sector | Health | Technology |
52-Week High | $168.62 | $14.03 |
52-Week Low | $113.50 | $7.34 |
Enterprise Value | $330.27B | $5.32B |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →VNET Group, formerly 21Vianet, is a leading carrier-neutral data center services provider in China. It operates a dual-core strategy: a large-scale retail business serving over 7,000 enterprise customers and an aggressive wholesale segment (Hyperscale 2.0) designed to meet the high-density power and cooling demands of large-scale AI and cloud platforms.
Read more on VNET →